Health Resources and Services Administration: Affordable Care Act - Immediate Facility Improvements Program

by: Iola Bonggay
The Health Resources and Services Administration(HRSA), under the supervision of the Department of Health and Human Services, is the country's premier agency for citizens who are insured, isolated, or medically vulnerable.

In keeping with this purpose, the HRSA mainly focuses on administering health care grants to eligible individuals, in order to help them obtain safe and quality care. Which is why, the HRSA also offers training to health professionals in rural communities in high hopes of constantly improving their systems of care.

The HRSA has recently developed the competitive Affordable Care Act Capital Development - Immediate Facility Improvements program, which gives funding opportunities to existing grantees of the Health Center Program as they address immediate and pressing financial needs, such as alteration/renovation projects at an existing facility, installation of life safety requirements at an existing facility, associated work required to modernize, improve, and/or reconfigure the interior arrangements or other physical characteristics of a facility.

The Affordable Care Act Capital Development - Immediate Facility Improvements Program will award approximately $100 million to 250-300 existing eligible Health Center Program Grantees.  (continued...)

Health Resources and Services Administration: Affordable Care Act - Immediate Facility Improvements Program
  Page 2

About The Author

Additional Resources

category - Health Grants

Research to Advance Vaccine Safety Program
The Centers for Disease Control and Prevention has partnered with the National Institutes of Health and as a result, has developed the Research to Advance Vaccine Safety Program, wherein it seeks to obtain a more thorough understanding vaccine safety.

---

Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.
The USFA has recently formed a collaboration with the National Institutes of Health to establish the Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.

---

Minor Use Minor Species Development of Drugs: Research Project Grant
The National Institutes of Health has partnered with the U.S. Food and Drug Administration (FDA) and the Center for Veterinary Medicine(CVM) in an effort to establish the Minor Use Minor Species Development of Drugs: Research Project Grant.

---

Excellence in Hemoglobinopathies Research Award Program
The National Institutes of Health has formed a collaboration with the National Heart, Lung, and Blood Institute (NHLBI) in an effort to establish the Excellence in Hemoglobinopathies Research Award Program wherein both agencies have agreed to financially support the creation of studies that could potentially improve high-impact multi-disciplinary basic and translational research studies in the hemoglobinopathies.

---